Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,903
Total Claims
$1.2M
Drug Cost
627
Beneficiaries
$1,986
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+38%
Opioid rate vs peers
3.1% vs 2.2% avg
+41%
Cost per patient vs peers
$1,986 vs $1,411 avg
+50%
Brand preference vs peers
16.0% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.1%
Opioid Rate
367
Opioid Claims
$12K
Opioid Cost
5.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,894 claims · $914K
Generic: 9,963 claims · $329K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 341 | $145K |
| Fluticasone/Umeclidin/Vilanter | 147 | $109K |
| Sitagliptin Phosphate | 106 | $65K |
| Semaglutide | 33 | $34K |
| Omeprazole/Sodium Bicarbonate | 11 | $31K |
| Empagliflozin | 75 | $26K |
| Fluticasone/Vilanterol | 51 | $26K |
| Alprazolam | 13 | $24K |
| Budesonide/Formoterol Fumarate | 48 | $24K |
| Fluticasone Propion/Salmeterol | 34 | $17K |
| Rivaroxaban | 28 | $15K |
| Dapagliflozin Propanediol | 23 | $15K |
| Umeclidinium Bromide | 25 | $15K |
| Umeclidinium Brm/Vilanterol Tr | 27 | $15K |
| Diclofenac Sodium | 53 | $13K |
Prescribing Profile
Patient Profile
78
Avg Age
58%
Female
2.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data